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In the framework of close interactions between the immune and neuroendocrine systems, 
Growth Hormone (GH) has been proposed to exert significant effects on the immune system, 
but there is not yet a consensus about GH immunomodulatory properties. 
These studies investigated the immune and anti-infectious response of dwarf Ghrh-/- mice 
presenting a severe deficiency of the GHRH/GH/IGF-1 axis. 
In basal conditions, thymic parameters and T-cell responses of Ghrh-/- mice were not 
severely affected but a constant B-cell lymphopaenia was observed. Thus, we investigated 
vaccine and anti-infectious responses of Ghrh-/- mice toward Streptococcus pneumonia, 
a B-dependent pathogen, 
Ghrh-/- mice were unable to trigger production of specific IgM and IgG against serotype 1 
pneumococcal polysaccharide (PPS) after vaccination with either native PPS (Pnx23) or 
protein-PPS conjugate (Prev-13) vaccines. These vaccines both include the serotype 1 (our 
S.pneumoniae strain) and provide an effective protection in mice. A short GH 
supplementation to Ghrh-/- mice (1 daily injection of 1 mg/kg GH for 4 weeks) restored IgM 
and IgG response to Pnx23 vaccine but not to Prev-13. This suggests that GH could exert 
distinct impacts upon spenic areas. 
Furthermore, after intranasal instillation of a non-lethal dose (defined by the full clearance by 
WT C57BL/6 mice after 24h) of serotype 1 S.pneumoniae, Ghrh-/- mice exhibited a dramatic 
susceptibility. This was proved by a marked time-dependent increase in pulmonary bacterial, 
a septicemia already 24h after infection and a survival limit of 72h. We also observed a 
dramatic decrease in lung B- and T-cell populations and an increase in proportion of 
inflammatory macrophages. By contrast, wild-type and heterozygote mice completely cleared 
S.pneumoniae infection after 24h. 
In conclusion, our data show without ambiguity that the somatotrope GHRH/GH/IGF-1 axis 
plays an important and unsuspected role in defense against S.Pneumoniae. 
 
 
 
 
 
 
 
